Adaptive Biotechnologies ADPT Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Adaptive Biotechnologies’s reported figures.
The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Adaptive Biotechnologies's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Adaptive Biotechnologies's free cash flow?
- Adaptive Biotechnologies (ADPT) reported free cash flow of -$10.33M in Q1 2026.
- How has Adaptive Biotechnologies's free cash flow changed year-over-year?
- Adaptive Biotechnologies's free cash flow increased by 65.3% year-over-year, from -$29.74M to -$10.33M.
- What is the long-term trend for Adaptive Biotechnologies's free cash flow?
- Over 4 years (2021 to 2025), Adaptive Biotechnologies's free cash flow has grown at a -33.3% compound annual growth rate (CAGR), from -$254.47M to -$50.36M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.